Clinical Trials Directory

Trials / Unknown

UnknownNCT05975346

Evaluation of the Efficacy of Preoperative Ketamine Nebulization on Postoperative Sore Throat Due to Tracheal Intubation for Adult Patients Under General Anesthesia, A Prospective Randomized Controlled Study

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
16 Years – 60 Years
Healthy volunteers

Summary

Sore throat includes specific symptoms such as dysphagia, dysphonia, hoarseness, continuous throat pain, and pharyngeal dryness. Patients rated postoperative sore throat (POST) as the eighth most undesirable outcome in the postoperative period POST has a reported incidence of up to 62% following general anesthesia (GA). The incidence of POST is more common in GA with tracheal intubation than in GA with the supraglottic airway Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist and has been used as a gargle for reducing the incidence and severity of POST due to its anti-nociceptive and anti-inflammatory effects

Conditions

Interventions

TypeNameDescription
DRUGKetaminedescription
OTHERsaline nebulizationdescription

Timeline

Start date
2023-08-01
Primary completion
2024-01-01
Completion
2024-01-01
First posted
2023-08-03
Last updated
2023-08-03

Source: ClinicalTrials.gov record NCT05975346. Inclusion in this directory is not an endorsement.

Evaluation of the Efficacy of Preoperative Ketamine Nebulization on Postoperative Sore Throat Due to Tracheal Intubation (NCT05975346) · Clinical Trials Directory